BAT is a leading multi-category consumer goods business dedicated to stimulating the senses of adult consumers worldwide. Our portfolio reflects our commitment to meeting the evolving and varied needs of today’s consumer who seeks sensorial enjoyment for different moods and moments.
For decades, we built our business on meeting the preferences of adult smokers with leading cigarette brands, superior products and market-leading innovations.
However, we recognise the world is changing.
We are building A Better Tomorrow™ for consumers by responsibly offering enjoyable and stimulating choices for every mood and every moment, today and tomorrow.
Our consumers are at the core of everything we do and our success is underpinned by addressing their preferences, offering them a choice of enjoyable, innovative and less risky products*† through:
These are our key brands in both the combustible and non-combustible categories. This ensures focus and investment on the brands and categories that will underpin the Group’s future performance.
Global Drive Brands
Our Reduced-Risk Portfolio (Non-Combustibles)*†
New Categories
Vapour
Tobacco Heating
Modern Oral
Traditional Oral
Combustible
Combustible Tobacco
U.S. -specific
Our transformation is backed by clear and measurable targets to increase consumers of our Smokeless Products to 50 million by 2030 and generate at least 50% of our revenue from Smokeless Products by 2035.
As of 30 June 2024, there are 26.4 million consumers of our Smokeless Products and revenue from Smokeless Products accounts for 17.9% of Group revenue.
We also have many international and local cigarette brands which, although not part of our Strategic Portfolio, remain popular in many countries in which we operate. These brands include Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A and State Express 555.
* Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
† Our Vapour product Vuse (including Alto, Solo, Ciro and Vibe), and certain products, including Velo, Grizzly, Kodiak, and Camel Snus, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.